Polyclonal mixture of diverse antigens

A polyclonal mixture of diverse antigens refers to a heterogeneous collection of multiple distinct antigenic molecules or epitopes rather than a single, well-defined molecular target. This concept is most frequently encountered in the context of polyvalent vaccines, such as those for Streptococcus pneumoniae or influenza, which aim to provide broad protection against multiple strains or serotypes of a pathogen (CDC, 2024). Because the mixture contains a variety of proteins, polysaccharides, or other macromolecules, it does not possess a single canonical structure or biological classification like a receptor or enzyme. Instead, it serves as a complex stimulus for the adaptive immune system, triggering the activation of numerous lymphocyte clones to produce a diverse array of antibodies and T-cell responses (NIH, 2023). In therapeutic contexts, this term is considered incorrect as a specific target because it lacks the molecular specificity required for targeted drug design or precise pharmacological characterization. It represents a class of therapeutic agents or a biological state rather than a discrete site of drug action (PubMed, 2022).

Other names

Multivalent antigensPolyvalent antigensComplex antigenic mixturesAntigenic cocktail

Induction of a broad, polyclonal immune response by presenting multiple distinct epitopes to B-cells and T-cells, leading to the production of a diverse repertoire of antibodies and effector cells (Janeway's Immunobiology, 2017).